Mr Luca Broggini
IRCCS San Donato Polyclinic, San Donato Milanese (Italy)
Nanobodies as novel potential drugs to target cardiac light chain amyloidosis
Event: Frontiers in CardioVascular Biomedicine 2022
Topic: Drugs, Drug Targets
Session: Poster Session 2
